Inhibikase Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | 02/13/2026 | 13.02 M | $26.69 M | 18.89% | 14.46% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 10.88 M | $22.29 M | 71.94% | 12.08% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/17/2026 | 8.63 M | $17.68 M | 40.82% | 9.58% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/18/2026 | 8.06 M | $16.53 M | 53.67% | 8.95% |
| 02/17/2026 | 6.18 M | $12.67 M | 100.00% | 6.86% | |
| BLACKSTONE INC. | 02/17/2026 | 5.94 M | $12.17 M | 125.08% | 6.59% |
| SIREN, L.L.C. | 02/13/2026 | 5.85 M | $11.99 M | 100.00% | 6.50% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 5.42 M | $11.11 M | 0.00% | 6.02% |
| COMMODORE CAPITAL LP | 02/17/2026 | 5.40 M | $11.06 M | 0.00% | 5.99% |
| VANGUARD GROUP INC | 01/29/2026 | 4.56 M | $9.35 M | 39.26% | 5.06% |
| 02/17/2026 | 4.23 M | $8.66 M | 100.00% | 4.69% | |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 3.93 M | $8.06 M | 79.42% | 4.36% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/17/2026 | 3.86 M | $7.91 M | 100.00% | 4.28% |
| 02/13/2026 | 3.58 M | $7.34 M | 100.00% | 3.98% | |
| BLACKROCK, INC. | 02/12/2026 | 3.31 M | $6.78 M | 7.49% | 3.67% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 2.35 M | $4.81 M | 219.47% | 2.61% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 1.75 M | $3.59 M | 100.00% | 1.94% |
| 02/13/2026 | 1.75 M | $3.59 M | 100.00% | 1.94% | |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 1.38 M | $2.82 M | 100.00% | 1.53% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.24 M | $2.55 M | 1,635.22% | 1.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.13 M | $2.31 M | 1.41% | 1.25% |
| EXOME ASSET MANAGEMENT LLC | 02/13/2026 | 600.00 K | $1.23 M | 100.00% | 0.67% |
| STATE STREET CORP | 02/13/2026 | 554.85 K | $1.14 M | 9.28% | 0.62% |
| 04/02/2026 | 533.65 K | $1.09 M | 100.00% | 0.59% | |
| NORTHERN TRUST CORP | 02/17/2026 | 322.72 K | $661.58 K | -13.79% | 0.36% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 169.85 K | $348.19 K | 100.00% | 0.19% |
| BLAIR WILLIAM & CO/IL | 02/17/2026 | 152.95 K | $313.55 K | 0.00% | 0.17% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 152.30 K | $312.21 K | 0.00% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 137.49 K | $281.84 K | -0.85% | 0.15% |
| JANE STREET GROUP, LLC | 02/12/2026 | 116.00 K | $237.81 K | 100.00% | 0.13% |
| BARCLAYS PLC | 02/13/2026 | 94.80 K | $194.33 K | 10.77% | 0.11% |
| UBS GROUP AG | 01/29/2026 | 94.55 K | $193.82 K | -30.62% | 0.11% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 93.43 K | $191.53 K | 100.00% | 0.10% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 85.27 K | $174.80 K | 694.29% | 0.09% |
| MORGAN STANLEY | 02/13/2026 | 79.68 K | $163.35 K | 42.24% | 0.09% |
| NUVEEN, LLC | 02/12/2026 | 78.66 K | $161.25 K | 0.00% | 0.09% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 67.83 K | $139.06 K | 48.29% | 0.08% |
| FMR LLC | 02/17/2026 | 57.37 K | $117.62 K | -45.76% | 0.06% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 54.91 K | $112.56 K | -31.79% | 0.06% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 47.90 K | $98.20 K | 0.00% | 0.05% |
| RHUMBLINE ADVISERS | 02/13/2026 | 47.16 K | $96.68 K | -18.05% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 46.41 K | $95.14 K | 171.38% | 0.05% |
| INVESCO LTD. | 02/19/2026 | 32.26 K | $66.14 K | -2.34% | 0.04% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 30.61 K | $63.00 K | 0.00% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/17/2026 | 28.88 K | $59.19 K | 3.26% | 0.03% |
| CAXTON CORP | 02/13/2026 | 28.45 K | $58.33 K | 73.57% | 0.03% |
| INTECH INVESTMENT MANAGEMENT LLC | 02/10/2026 | 26.88 K | $55.11 K | -15.77% | 0.03% |
| JPMORGAN CHASE & CO | 02/11/2026 | 24.85 K | $50.94 K | -50.24% | 0.03% |
| VIRTU FINANCIAL LLC | 02/23/2026 | 22.87 K | $47.00 K | 70.08% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 21.53 K | $44.14 K | -52.79% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibikase Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 85 institutional investors and hedge funds held shares of Inhibikase Therapeutics Inc. The most heavily invested institutionals were:
Sands Capital Ventures, LLC: 13.02 M
VANGUARD FIDUCIARY TRUST CO: 566,999
Nuveen, LLC: 472,399
UBS Group AG: 228,151
Bank of New York Mellon Corp: 213,208
BLAIR WILLIAM & CO/IL: 157,988
118.17% of Inhibikase Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 91.53 M shares in the last 24 months. This purchase volume represents approximately $172.99 M in transactions.